Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glycosyltransferase 6 domain-containing protein 1 (GLT6D1) is a member of the glycosyltransferase 6 gene family and encodes a putative enzyme with probable hexosyltransferase activity. In humans, the GT6 gene family includes the functional ABO blood group gene, but the precise substrate and physiological role of GLT6D1 remain unclear. Variants of GLT6D1 have been identified as genetic susceptibility loci for aggressive periodontitis through genome-wide association studies, with high gene expression detected in leukocytes and gingival tissue. The molecular function is annotated as possible involvement in glycan biosynthesis, but to date there are no known drugs specifically targeting this protein, and its role as a validated therapeutic target has not been established[3][4][6][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycosyltransferase 6 domain-containing protein 1 (GLT6D1).